Clinical Trial Update: Protective Effects of L-arginine During Reperfusion by Femoropopliteal Bypass for Lower Limb Ischemic Syndrome in Humans [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether L-arginine protects skeletal muscle during reperfusion in femoropopliteal bypass for severe lower limb ischemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Peripheral Artery Disease

Drugs mentioned

• L-Arginine (L-Arginine)

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Skeletal Muscle Ischemia, Severe Lower Limb Ischemia | Phase 4 | Status: COMPLETED